U.S. Beverage Stock News

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Resideo Technologies, Inc. ( NYSE:REZI ) shares have continued their recent momentum with a 29% gain in the last month...

Key Insights The considerable ownership by private companies in SuperX AI Technology indicates that they collectively...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

In July 2025, Oscar Health revised its full-year 2025 guidance, projecting total revenue between US$12.0 billion and US$12.2 billion and an operating loss of US$300 million to US$200 million. This update underscores the company’s ongoing struggle to achieve profitability even as it forecasts robust top-line growth for the year. We'll explore how projecting continued operating losses alongside rising revenue shapes Oscar Health's investment outlook and potential risks. The best AI stocks...

Unfortunately for some shareholders, the Baird Medical Investment Holdings Limited ( NASDAQ:BDMD ) share price has...

Orion Group Holdings ( NYSE:ORN ) Second Quarter 2025 Results Key Financial Results Revenue: US$205.3m (up 6.8% from 2Q...

In July 2025, Abercrombie & Fitch expanded its retail presence by partnering with Macy’s to offer Abercrombie Kids products for the back-to-school season and launched a Hollister anniversary capsule collection tapping into Y2K nostalgia. This dual approach not only targets key school-age and young adult demographics, but also leverages cross-channel merchandising to optimize supply chain efficiencies and broaden brand reach. Next, we'll assess how the Macy's collaboration may strengthen...

Motorcar Parts of America, Inc. ( NASDAQ:MPAA ) shareholders might be concerned after seeing the share price drop 11...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

With a price-to-earnings (or "P/E") ratio of 10.6x Neo-Concept International Group Holdings Limited ( NASDAQ:NCI ) may...

IDEAYA Biosciences recently announced it will host an in-person and virtual R&D Day in September 2025, where the company plans to present multiple clinical data updates and discuss upcoming growth milestones. This dual-format event aims to boost the company’s engagement with stakeholders by providing fresh insights into its pipeline developments and future trajectory. We’ll explore how anticipation for IDEAYA’s upcoming R&D Day and clinical data presentations could shape the company’s...

Key Insights Significant control over HF Foods Group by individual investors implies that the general public has more...

Freshworks ( NASDAQ:FRSH ) Second Quarter 2025 Results Key Financial Results Revenue: US$204.7m (up 18% from 2Q 2024...

Earlier this week, Astronics saw its shares fall after an extended rally, as investors cashed in gains despite no adverse company news and shortly after launching a new communications system analyzer for Land Mobile Radio testing. This pullback occurred despite a noteworthy product release, highlighting how profit-taking following strong share price gains can outweigh recent operational announcements in influencing short-term investor sentiment. We'll explore how the recent technical...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

There's been a notable change in appetite for Teladoc Health, Inc. ( NYSE:TDOC ) shares in the week since its...

Key Insights Given the large stake in the stock by institutions, Astronics' stock price might be vulnerable to their...

Northwest Bancshares ( NASDAQ:NWBI ) Second Quarter 2025 Results Key Financial Results Revenue: US$141.6m (up 44% from...

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

On July 30, 2025, OneSpaWorld Holdings reported second-quarter earnings with revenue rising to US$240.73 million and net income of US$19.94 million, alongside a quarterly dividend declaration and reaffirmed full-year revenue guidance. An interesting highlight is that even with higher second-quarter profits, the company's net income for the first half of 2025 trailed slightly behind the same period last year, indicating both growth and ongoing business pressures. Now, we'll examine how the...

Quite a few insiders have dramatically grown their holdings in Akari Therapeutics, Plc ( NASDAQ:AKTX ) over the past 12...

Key Insights The projected fair value for Global Industrial is US$55.83 based on 2 Stage Free Cash Flow to Equity...